Serum adiponectin confers little protection against diabetes and hypertension in Turkish men

Obesity

Volumn 17, Issue 3, 2009, Pages 564-570

  Onat, Altan ^a,b   Hergenç, Gülay ^c   Can, Günay ^b   Küçükdurmaz, Zekeriya ^d  

^a Turkish Society of Cardiology   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^d GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; SEX HORMONE BINDING GLOBULIN;

ARTICLE; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSIOLOGY; PREVALENCE; REGRESSION ANALYSIS; RISK FACTOR; SEXUAL DEVELOPMENT; TURKEY (REPUBLIC);

ADIPONECTIN; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEX CHARACTERISTICS; SEX HORMONE-BINDING GLOBULIN; TURKEY;

EID: 60849138823     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.564     Document Type: Article

References (35)

1. Maeda K, Okubo K, Shimomura I et al. CDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (Adipose Most Abundant Gene Transcript 1 ). Biochem Biophys Res Commun 1996;221:286-289.
2. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
3. Cnop M, Havel PJ, Utzschneider KM et al. Relatioship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469.
4. Daimon M, Oizumi T, Saitoh T et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003;26:2015-2020.
5. Choi KM, Lee J, Lee KW et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome In elderly Koreans. Clin Endocrinol 2004;61:75-80.
6. Snehalatha C, Muktesh B, Simon M et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26:3226-3229.
7. Iwashima Y, Katsuya T, Ishikawa K et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004;43:1318-1323.
8. Chow W-S, Cheung BMY, Tso AWK et al. Hypoadinopectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007;49:1455-1466.
9. Rothenbacher D, Brenner H, März W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 2005;26:1640-1646.
10. Lawlor DA, Davey Smith G, Ebrahim S et al. Plasma adiponectin levels are associated with insulin resistance, but do not predict coronary heart disease risk in women. J Clin Endocrinol Metab 2005;90:5677-5683.
11. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo Study. Am J Epidemiol 2007;165:164-174.
12. Hulthe J, Hulten LM, Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: Atherosclerosis and Insulin Resistance study. Metabolism 2003;52:1612-1614.
13. Matsushita K, Yatsuya H, Tamakoshi K et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome In Japanese men. Arterioscler Thromb Vasc Biol 2006;26:871-876.
14. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975-981.
15. Ouchi N, Kihara S, Funahashi T et al. Reciporocal association of C-reactive protein with adiponectin in blood steam and adipose tissue. Circulation 2003;107:671-674.
16. Engeli S, Feldpausch M, Gorzelniak K et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003;52:942-947.
17. Onat A, Ceyhan K, Başar Ö et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285-292.
18. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001;156:1-10.
19. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
20. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
21. Onat A, Uyarel H, Hergenç G et al. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007;191:182-190.
22. Genuth S, Alberti KG, Bennett P et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26:3160-3167.
23. Mather KJ, Hunt AE, Steinberg HO et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001 ;86:5457-5464.
24. Iwashima Y, Katsuya T, Ishikawa K et al. Association with hypoadiponectinemia with smoking habit in men. Hypertension 2005;45:1094-1100.
25. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004;27:1680-1687.
26. Faraj M, Messier L, Bastard JP et al. Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetobgia 2006;49:1637-1646.
27. Onat A, Can G, Hergenç G et al. Serum apolipoprotein B predicts dyslipldemia, metabolic syndrome and, in women, hypertension, diabetes, independent of markers of central obesity and inflammation. Int J Obes 2007;31:1119-1125.
28. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
29. Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-1063.
30. Onat A, Hergenç G, Karabulut A et al. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Metabolism 2007;56:1356-1362.
31. Kazumi T, Kawaguchi A, Sakal K, Hirano T, Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002;257:971-976.
32. Haffner SM, Laakso M, Miettinen H et al. Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. J Clin Endocrinol Metab 1996;81:3697-3701.
33. Laaksonen DE, Niskanen L, Punnonen K et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005;90:712-719.
34. Onat A, Özhan H, Erbilen E et al. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. Int J Cardiol 2008; e-pub ahead of print 24 Jun 2008.
35. Halperin F, Beckman JA, Patti ME et al. The role of total and high-molescular weight complex of adiponectin in vascular function in offspring whose parents both had type 2 diabetes. Diabetologia 2005;48: 2147-2154.